Analyst Ratings for Xeris Pharmaceuticals (XERS)
XERS Rating Summary
XERS Price Target Summary
- Highest: $18.00 (Oppenheimer)
- Lowest: $8.00 (Piper Sandler)
- Average: $10.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.71 (+21.8%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 81%
Avg. $ Target:
$10.71 (+21.8%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 81%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/12/2025 | H.C. Wainwright | Brandon Folkes | New Coverage | Buy (N/A) |
10.00 (N/A) |
7.20 (8.80) |
22.22% | Details |
| 11/11/2024 | Piper Sandler » Updated 11/7/2025 |
David Amsellem | Downgrade | Neutral (Overweight) |
8.00 (6.00) |
3.36 (8.80) |
161.9% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
